Technical Analysis for AMYT - Amryt Pharma Plc

Grade Last Price % Change Price Change
F 161.5 -1.52% -2.50
AMYT closed down 1.52 percent on Tuesday, May 11, 2021, on 2.47 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical AMYT trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish -1.52%
Calm After Storm Range Contraction -1.52%
Lower Bollinger Band Walk Weakness -1.52%
Older End-of-Day Signals for AMYT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Amryt Pharma Plc Description

Amryt Pharma plc, formerly Fastnet Equity plc, is a United Kingdom-based specialty pharmaceutical company. The Company focuses on developing and delivering treatments for patients with rare and orphan diseases. The Company’s products include Episalvan and Imlan. The Company’s products focus on developing somatostatin analogue (SSA) peptide medicines for patients with rare neuroendocrine diseases, including acromegaly and Cushing's disease. The Company’s Episalvan is a prescription pharmaceutical product, which accelerates wound healing. The Company’s Episalvan consists of two ingredients, such as betulin-based active ingredient and sunflower oil as the excipient. The Company's Imlan products have regenerative and anti-inflammatory properties. Betulin is the active ingredient in the Imlan products and functions as the stabilizer of the creams and lotions. The Company’s Imlan Creme Pur consists of Betulin, oil and water ingredients.


Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Oil Health Water Pharmaceutical Medicine Disease Diseases Mr Ingredient Pharmaceutical Industry Health Sciences Pharmacy Pharmacology Dosage Forms Active Ingredient Pharmaceutical Sciences Orphan Diseases Sunflower Oil

Is AMYT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 250.0
52 Week Low 80.0
Average Volume 125,379
200-Day Moving Average 198.21
50-Day Moving Average 202.50
20-Day Moving Average 194.61
10-Day Moving Average 186.55
Average True Range 9.79
ADX 27.9
+DI 7.21
-DI 28.41
Chandelier Exit (Long, 3 ATRs ) 180.62
Chandelier Exit (Short, 3 ATRs ) 189.68
Upper Bollinger Band 223.52
Lower Bollinger Band 165.71
Percent B (%b) -0.07
BandWidth 29.71
MACD Line -9.42
MACD Signal Line -5.03
MACD Histogram -4.3836
Fundamentals Value
Market Cap 262.93 Million
Num Shares 163 Million
EPS -10.80
Price-to-Earnings (P/E) Ratio -14.95
Price-to-Sales 2.35
Price-to-Book 5.90
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 174.55
Resistance 3 (R3) 175.60 172.30 172.37
Resistance 2 (R2) 172.30 168.98 171.77 171.65
Resistance 1 (R1) 166.90 166.92 165.25 165.85 170.92
Pivot Point 163.60 163.60 162.78 163.08 163.60
Support 1 (S1) 158.20 160.28 156.55 157.15 152.08
Support 2 (S2) 154.90 158.22 154.38 151.35
Support 3 (S3) 149.50 154.90 150.63
Support 4 (S4) 148.45